ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
"The reasons for these findings likely represent our lack of a complete understanding of the factors involved in no-reflow/distal embolization phenomena." The use of a distal embolic protection device ...
Elective carotid artery angioplasty and stenting was initiated in the United States in 1994 by the endovascular interventional team at the University of Alabama at Birmingham. Carotid stenting was ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
United States Embolic Protection Device Market is expected to reach US$ 650 million by 2033 from US$ 360 million in 2024, with a CAGR of 6.96% from 2025 to 2033. Rising cardiovascular operations, ...
Illustration of a sinusoidal thrombus capture wire positioned between two expandable spheres, designed for effective clot removal in vascular procedures. The distal sphere expands to anchor and ...
€2.1M Grant to support Filterlex's CAPTIS clinical trials YOKNEAM, Israel, Sept. 16, 2019 /PRNewswire/ -- Filterlex Medical, an innovative medical device startup in the cardiovascular field, today ...
(MENAFN- EIN Presswire) EINPresswire/ -- The Embolic Protection Devices Market is gaining significant traction globally, driven by the rising prevalence of cardiovascular diseases, increasing adoption ...
(MENAFN- GlobeNewsWire - Nasdaq) Key states, including California and Texas, lead in demand due to advanced healthcare systems and aging populations Dublin, Dec. 29, 2025 (GLOBE NEWSWIRE) -- The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results